The U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) will discuss common objectives and challenges in pharmacovigilance and clinical safety at DIA’s Annual Meeting June 15-19 in San Diego.
The June 17 session, FDA-EMA Collaboration in Pharmacovigilance: Common Objectives and Common Challenges, will focus on joint efforts in drug-specific evaluation, drug development, effective implementation of new pharmacovigilance (medicine safety) tools and addressing common challenges.
Help employers find you! Check out all the jobs and post your resume.
